CVLLY (CellaVision AB) Forward Dividend Yield %: 2.11% (As of Jun. 24, 2026)


CVLLY CellaVision AB CVLLY
69 GF Score
Price $7.06
GF Value $12.48
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is CellaVision AB Forward Dividend Yield %?

CellaVision AB CVLLY +12.06% 69 Forward Dividend Yield % is 2.11% as of Jun. 24, 2026. GuruFocus rates CVLLY with a GF Score™ of 69/100 and a GF Value™ of $12.48 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 316 Medical Devices & Instruments companies, CellaVision AB ranks worse than 50.95% on this metric.

As of today (2026-06-24), the Forward Annual Dividend Yield of CellaVision AB is 2.11%.

As of today (2026-06-24), the Trailing Annual Dividend Yield of CellaVision AB is 2.11%.

CVLLY's Forward Dividend Yield % is ranked worse than
50.95% of 316 companies
in the Medical Devices & Instruments industry
Industry Median: 2.095 vs CVLLY: 2.11

CellaVision AB's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

During the past 12 months, CellaVision AB's average Dividends Per Share Growth Rate was 11.10% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 7.70% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of CellaVision AB was 55.40% per year. The lowest was -20.60% per year. And the median was 14.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


CellaVision AB  (OTCPK:CVLLY) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


CellaVision AB Forward Dividend Yield % Related Terms


CVLLY vs ABT, SYK, MDT: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, CellaVision AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Forward Dividend Yield % falls into.


CVLLY
69GF Score
CellaVision AB CVLLY
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellaVision AB Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

CellaVision AB Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.1487492026-04-302026-04-302026-05-20Cash DividendannuallyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

CellaVision AB's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.148749/7.06
=2.11 %

Current Share Price is $7.06.
CellaVision AB's Dividends per Share for the forward twelve months is calculated as $0.148749 * 1 = $0.148749.

CellaVision AB's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.148749/7.06
=2.11 %

Current Share Price is $7.06.
CellaVision AB's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.148749.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 2.11% mean?
CellaVision AB (CVLLY) has a Forward Dividend Yield % of 2.11% as of Jun. 24, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on CellaVision AB and its competitors. According to the industry distribution chart, CellaVision AB ranks #161 out of 316 companies in the Medical Devices & Instruments industry, placing it in the top 50.9%.
Is CellaVision AB's Forward Dividend Yield % too high?
CellaVision AB's current Forward Dividend Yield % is 2.11%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.10. CellaVision AB's value of 2.11% is 0.7% above this industry median. Based on the distribution chart, CellaVision AB ranks #161 out of 316 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, CellaVision AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellaVision AB's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CellaVision AB ranks #161 out of 316 companies for Forward Dividend Yield %. This places CellaVision AB in the lower half of its industry. The industry median Forward Dividend Yield % is 2.10. CellaVision AB's value of 2.11% is 0.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.10, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CellaVision AB's current Forward Dividend Yield % of 2.11% is 0.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on CellaVision AB and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CellaVision AB's current Forward Dividend Yield % is 2.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellaVision AB stock overvalued right now?
Based on GuruFocus' analysis, CellaVision AB (CVLLY) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.48, compared to a current price of $7.06 — trading 43.4% below its estimated fair value. The current Forward Dividend Yield % is 2.11% and 0.7% above the Medical Devices & Instruments industry median of 2.10. CellaVision AB's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For CellaVision AB (CVLLY), the current Forward Dividend Yield % is 2.11% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellaVision AB (CVLLY) Overvalued in 2026?

Based on GuruFocus' analysis, CellaVision AB stock appears to be undervalued. The current stock price of $7.06 is trading 43.4% below its estimated GF Value™ of $12.48. GuruFocus considers CellaVision AB to be Significantly Undervalued.

Key valuation signals for CVLLY:

  • Forward Dividend Yield %: 2.11%
  • GF Value™: $12.48 vs. price of $7.06 (43.4% below fair value)
  • GF Score™: 69/100 with 1 warning sign
  • Industry Position: 0.7% above the Medical Devices & Instruments median (#161 of 316)

No single metric tells the full story. See the CVLLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CellaVision AB Business Description

Address Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.
69GF Score

Get the complete analysis for CVLLY

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.06
Price
$12.48
GF Value